Evogene Ltd (NASDAQ: EVGN)
$0.64
+0.0020 ( +0.31% ) 180.0K
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.
Market Data
Open
$0.64
Previous close
$0.64
Volume
180.0K
Market cap
$32.42M
Day range
$0.62 - $0.67
52 week range
$0.45 - $1.20
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 4 | Jun 25, 2024 |
6-k | Quarterly Reports | 1 | Jun 20, 2024 |
6-k | Quarterly Reports | 1 | Jun 17, 2024 |
6-k | Quarterly Reports | 1 | Jun 06, 2024 |
6-k | Quarterly Reports | 45 | May 29, 2024 |
6-k | Quarterly Reports | 31 | May 23, 2024 |
6-k | Quarterly Reports | 4 | May 23, 2024 |
6-k | Quarterly Reports | 6 | Apr 30, 2024 |
6-k | Quarterly Reports | 5 | Apr 02, 2024 |
20-f | Annual reports | 122 | Mar 28, 2024 |